Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma-Reference-Cited by-同舟云学术

Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma

Published:2024-03-20 Issue:6 Volume:65 Page:746-757
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gao Lin-Rui¹^ORCID,Wang Xinyue¹,Wu Yunpeng¹,Feng Xiao-Li²,Rao Wei²,Liu Xin¹,Song Yong-Wen¹,Fang Hui¹,Chen Bo¹,Jin Jing¹,Liu Yue-Ping¹,Jing Hao¹,Tang Yuan¹,Lu Ning-Ning¹,Li Ning¹,Zhang Wen-Wen¹,Zhai Yirui¹,Wang Shu-Lian¹,Qi Shu-Nan¹,Li Ye-Xiong¹^ORCID

Affiliation:

1. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China

2. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2329328

Reference39 articles.

1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

2. Survival of patients with marginal zone lymphoma

3. Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000–2015)

4. Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study

5. Swerdlow S, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC; 2017.